Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Discoid Lupus Erythematosus
In brief
A Phase 2, double-blind, randomized, placebo-controlled parallel-group study to evaluate the efficacy and safety of daxdilimab in participants with moderate-to-severe active primary Discoid Lupus Erythematosus (DLE) refractory to standard of care.
Key facts
- Study ID
- NCT05591222
- Run by
- Amgen
- People needed
- 72
- Starts
- 2022-12-29
- Expected to finish
- 2025-05-08
- Last updated by the study team
- 2026-05-14
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Wallace Medical Group — Beverly Hills, California, United States
- The Center for Dermatology Clinical Research — Fremont, California, United States
- Clinical Science Institute — Santa Monica, California, United States
- Miami Dermatology & Laser Research — Miami, Florida, United States
- Dawes Fretzin Clinical Research Group, LLC — Indianapolis, Indiana, United States
- Detroit Clinical Research Center, PC — Farmington Hills, Michigan, United States
- Michigan Dermatology Institute — Waterford, Michigan, United States
- Minnesota Clinical Study Center — New Brighton, Minnesota, United States
- MediSearch Clinical Trials — Saint Joseph, Missouri, United States
- Forest Hills Dermatology — Forest Hills, New York, United States
- Ohio State University — Columbus, Ohio, United States
- Wright State Physicians — Fairborn, Ohio, United States
- Paddington Testing Company, Inc. — Philadelphia, Pennsylvania, United States
- Autoimmune Skin Diseases Unit, Dept. of Dermatology — Philadelphia, Pennsylvania, United States
- Center for Clinical Studies (Cypress) — Houston, Texas, United States
- Fundacion Scherbovsky — Mendoza, Mendoza Province, Argentina
- CIPREC — Ciudad Autonoma Buenos Aires, Argentina
- HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará — Fortaleza, Ceará, Brazil
- Hospital Universitário Evangélico Mackenzie — Água Verde, Paraná, Brazil
- Fundação Faculdade Regional de Medicina de São José do Rio Preto, CIP - Centro Integrado de Pesquisa — Sao Jose Rio, Preto Sao Paulo, Brazil
- Complexo Hospitalar de Niterói — Niterói, Rio Do Janeiro, Brazil
- Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A — Rio de Janeiro, Rio Do Janeiro, Brazil
- Fundação Universidade de Caxias do Sul - Instituto de Pesquisas em Saúde da Universidade de Caxias do Sul — Caxias do Sul, Rio Grande do Sul, Brazil
- Hospital Moinhos de Vento — Porto Alegre, Rio Grande do Sul, Brazil
- Arkansas Research Trials — North Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.